Subsequent Events (Details) $ in Thousands |
Oct. 04, 2017
USD ($)
shares
|
|---|---|
| Acquisition of Promet Therapeutics LLC | |
| Common stock issued for acquisition | shares | 222,217,000 |
| Percentage of issued and outstanding stock issued in merger | 90.00% |
| October 4, 2017 | |
| Proceeds from senior convertible notes | $ | $ 1,250 |
| X | ||||||||||
- Definition Number of shares of equity interests issued or issuable to acquire entity. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition Percentage of voting equity interests acquired at the acquisition date in the business combination. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Definition The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|